Resonance Specialties Limited (BOM:524218)

Market Cap	1.26B +36.8%
Revenue (ttm)	899.72M +28.6%
Net Income	88.58M +112.0%
EPS	7.71 +113.0%
Shares Out	11.54M
PE Ratio	14.11
Forward PE	n/a
Dividend	1.00 (0.92%)
Ex-Dividend Date	n/a

Volume	37,437
Average Volume	7,039
Open	106.89
Previous Close	107.16
Day's Range	105.02 - 109.90
52-Week Range	75.60 - 124.50
Beta	0.26
RSI	69.18
Earnings Date	May 14, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate,...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 66
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524218

Financial Performance

In fiscal year 2025, Resonance Specialties's revenue was 778.07 million, an increase of 40.70% compared to the previous year's 553.01 million. Earnings were 65.66 million, an increase of 121.20%.